Science Explorer Back to mapMap
Discussion
Researcher · Kyowa Kirin (Japan) · Japan

Kenya Shitara

Kenya Shitara publishes mostly in Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology, on topics such as Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research and Galectins and Cancer Biology.

OpenAlex
World rank
#247,784
of 7,710,434 ranked researchers
Rank in Japan
#1,964
of 383,136
Works
107
Citations
9.6k
Citations per work
90.0
h-index
44
i10-index 73Top 5.5% in Molecular Biology
Kenya Shitara

What does Kenya Shitara research?

Kenya Shitara's work is mostly in Biochemistry, Genetics and Molecular Biology (38%), Medicine (30%), Immunology and Microbiology (13%).

Life Sciences: 55 works · 51.2% of their workBiochemistry, Genetics and Molecular Biology: 41 works · 38.1% of their workMolecular Biology: 37 works · 34.6% of their workBiotechnology: 4 works · 3.5% of their workImmunology and Microbiology: 14 works · 13.1% of their workImmunology: 14 works · 13.1% of their workHealth Sciences: 32 works · 30.1% of their workMedicine: 32 works · 30.1% of their workRadiology, Nuclear Medicine and Imaging: 23 works · 21.6% of their workOncology: 6 works · 5.3% of their workImmunology and Allergy: 3 works · 3.2% of their workEverything else: 20 works · 18.7% of their workTHEIR WORKKenya Shitara107works
Life Sciences51%Health Sciences30%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology4138.1%
    2. Immunology and Microbiology1413.1%
    1. Medicine3230.1%
  3. Everything else2018.7%
  1. 1Molecular Biology35% of their works
  2. 2Radiology, Nuclear Medicine and Imaging22% of their works
  3. 3Immunology13% of their works
  4. 4Oncology5% of their works
  5. 5Biotechnology4% of their works
  6. 6Immunology and Allergy3% of their works

Research topics

Which keywords describe Kenya Shitara's research?

The keywords of their largest research topics: Glycosylation, Cancer, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Glycans and Immune System.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Glycosylation1253 topics
  2. Cancer813 topics
  3. Monoclonal Antibodies662 topics
  4. Therapeutic Antibodies662 topics
  5. Antibody Engineering601 topic
  6. Fc Receptors601 topic
  7. Glycans581 topic
  8. Immune System581 topic
  9. Angiogenesis293 topics
  10. Inflammation293 topics
  11. Galectins141 topic
  12. Immune Regulation141 topic
  13. Cell Adhesion91 topic
  14. Integrins91 topic
  15. VEGF91 topic
  16. endothelial progenitor cells91 topic
  17. Mammalian Cells71 topic
  18. Recombinant Protein71 topic
  19. Biopharmaceuticals61 topic
  20. Hyaluronan61 topic
  21. Protein Aggregation61 topic
  22. Proteoglycans61 topic

Where does Kenya Shitara work?

Kenya Shitara's main affiliation in the publication record is Kyowa Kirin (Japan), Japan.

How many publications and citations does Kenya Shitara have?

OpenAlex counts 107 works and 9,631 citations for Kenya Shitara, an h-index of 44, ranking #247,784 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Kenya Shitara. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.